Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts

Stem Cells and Development

Volumn 23, Issue 13, 2014, Pages 1515-1523

  Whitworth, Deanne J ^a   Ovchinnikov, Dmitry A ^a   Sun, Jane ^a   Fortuna, Patrick R J ^a   Wolvetang, Ernst J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALKALINE PHOSPHATASE; BETA TUBULIN; FIBROBLAST GROWTH FACTOR 2; KRUPPEL LIKE FACTOR 4; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MYC PROTEIN; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; STAGE SPECIFIC EMBRYO ANTIGEN 4; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NANOG; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; HISTONE; TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYOID BODY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IMAGING; GERM LAYER; HORSE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KARYOTYPE; KARYOTYPING; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; TERATOMA; X CHROMOSOME; ANIMAL; COCULTURE; CYTOLOGY; FEEDER CELL; FIBROBLAST; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; SKIN;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEEDER CELLS; FEMALE; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; GENE EXPRESSION; HISTONES; HORSES; INDUCED PLURIPOTENT STEM CELLS; LEUKEMIA INHIBITORY FACTOR; SKIN; TRANSCRIPTION FACTORS; X CHROMOSOME;

EID: 84903183230     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0461     Document Type: Article

References (28)

1. Tecirlioglu RT and AO Trounson. (2007). Embryonic stem cells in companion animals (horses, dogs and cats): Present status and future prospects. Reprod Fertil Dev 19:740-747. (Pubitemid 47206972)
2. Perkins NR, SW Reid and RS Morris. (2005). Risk factors for injury to the superficial digital flexor tendon and suspensory apparatus in Thoroughbred racehorses in New Zealand. N Z Vet J 53:184-192. (Pubitemid 40814361)
3. Sarrafian TL, JT Case, H Kinde, BM Daft, DH Read, JD Moore, FA Uzal and SM Stover. (2012). Fatal musculoskeletal injuries of Quarter Horse racehorses: 314 cases (1990-2007). J Am Vet Med Assoc 241:935-942.
4. Vidal MA, GE Kilroy, JR Johnson, MJ Lopez, RM Moore and JM Gimble. (2006). Cell growth characteristics and differentiation frequency of adherent equine bone marrowderived mesenchymal stromal cells: Adipogenic and osteogenic capacity. Vet Surg 35:601-610. (Pubitemid 44526659)
5. Borjesson DL and JF Peroni. (2011). The regenerative medicine laboratory: Facilitating stem cell therapy for equine disease. Clin Lab Med 31:109-123.
6. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
7. Nagy K, HK Sung, P Zhang, S Laflamme, P Vincent, S Agha-Mohammadi, K Woltjen, C Monetti, IP Michael, LC Smith and A Nagy. (2011). Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev 7:693-702.
8. Khodadadi K, H Sumer, M Pashaiasl, S Lim, M Williamson and PJ Verma. (2012). Induction of pluripotency in adult equine fibroblasts without cMyc. Stem Cells Int [Epub ahead of print]; DOI: 10.1155/2012/429160.
9. Breton A, R Sharma, AC Diaz, AG Parham, A Graham, C Neil, CB Whitelaw, E Milne and FX Donadeu. (2013). Derivation and characterization of induced pluripotent stem cells from equine fibroblasts. Stem Cells Dev 22:611-621.
10. Saito S, H Ugai, K Sawai, Y Yamamoto, A Minamihashi, K Kurosaka, Y Kobayashi, T Murata, Y Obata and K Yokoyama. (2002). Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro. FEBS Lett 531:389-396. (Pubitemid 35336057)
11. Li X, SG Zhou, MP Imreh, L Ahrlund-Richter and WR Allen. (2006). Horse embryonic stem cell lines from the proliferation of inner cell mass cells. Stem Cells Dev 15: 523-531. (Pubitemid 44701172)
12. Whitworth DJ, DA Ovchinnikov and EJ Wolvetang. (2012). Generation and characterization of LIF-dependent canine induced pluripotent stem cells from adult dermal fibroblasts. Stem Cells Dev 21:2288-2297.
13. Stenberg J,MElovsson, R Strehl, E Kilmare, J Hyllner and A Lindahl. (2011). Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology 63:227-237.
14. Stachelscheid H, A Wulf-Goldenberg, K Eckert, J Jensen, J Edsbagge, P Björquist, M Rivero, R Strehl, J Jozefczuk, et al. (2013). Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors. J Tissue Eng Regen Med 7:729-741.
15. Payer B, JT Lee and SH Namekawa. (2011). X-inactivation and X-reactivation: Epigenetic hallmarks of mammalian reproduction and pluripotent stem cells. Hum Genet 130: 265-280.
16. Pera MF and PPL Tam. (2010). Extrinsic regulation of pluripotent stem cells. Nature 465:713-720.
17. Chou YF, HH Chen, M Eijpe, A Yabuuchi, JG Chenoweth, P Tesar, J Lu, RD McKay and N Geijsen. (2008). The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell 135:449-461.
18. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199. (Pubitemid 47067378)
19. Hanna J, S Markoulaki, M Mitalipova, AW Cheng, JP Cassady, J Staerk, BW Carey, CJ Lengner, R Foreman, et al. (2009). Metastable pluripotent states in NOD-mousederived ESCs. Cell Stem Cell 4:513-524.
20. Greber B, G Wu, C Bernemann, JY Joo, DW Han, K Ko, N Tapia, D Sabour, J Sterneckert, P Tesar and HR Schö ler. (2010). Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6:215-226.
21. Nichols J, J Silva, M Roode and A Smith. (2009). Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136: 3215-3222.
22. Armstrong L, O Hughes, S Yung, L Hyslop, R Stewart, I Wappler, H Peters, T Walter, P Stojkovic, et al. (2006). The role of PI3K/AKT, MAPK/ERK and NFkb signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15:1894-1913. (Pubitemid 43821780)
23. Takahashi K, M Murakami and S Yamanaka. (2005). Role of phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. Biochem Soc Trans 33:1522-1525. (Pubitemid 41779729)
24. Eiselleova L, K Matulka, V Kriz, M Kunova, Z Schmidtova, J Neradil, B Tichy, D Dvorakova, S Pospisilova, A Hampl and P Dvorak. (2009). A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 27:1847-1857.
25. Niwa H, K Ogawa, D Shimosato and K Adachi. (2009). A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460:118-122.
26. Kinehara M, S Kawamura, D Tateyama, M Suga, H Matsumura, S Mimura, N Hirayama, M Hirata, K Uchio-Yamada, et al. (2013). Protein kinase C regulates human pluripotent stem cell self-renewal. PLOS One 8:1-13.
27. Stiles B, V Gilman, N Khanzenzon, R Lesche, A Li, R Qiao, X Liu and H Wu. (2002). Essential role of AKT-1/ protein kinase B alpha in PTEN-controlled tumorigenesis. Mol Cell Biol 22:3842-3851. (Pubitemid 34525225)
28. Jirmanova L, M Afanassieff, S Gobert-Gosse, S Markossian and P Savatier. (2002). Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21:5515-5528. (Pubitemid 34983541)